Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

TV star and model Danielle Lloyd has revealed she’s been diagnosed with skin cancer at the age of 41. The former beauty ...

On World Cancer Day 2025, learn about 10 warning signs of cancer you shouldn’t ignore, from unexplained weight loss to ...

Cancer is affecting increasing numbers of young women with the hormone oestrogen thought to play to a central role ...

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

Collaboration to take Cytovation's synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinoma <li /> Ca ...

Stopping smoking has been shown to allow cells that have avoided damage from the cancer-causing chemicals in tobacco smoke ..